Aberrant maspin expression in human endometrial cancer

Shinya Murai1, Chihaya Maesawa, Tomoyuki Masuda

  • 1Department of Obstetrics and Gynecology, School of Medicine, Iwate Medical University, Uchimaru 19-1, Morioka, Iwate 020-8505, Japan.

Cancer Science
|July 11, 2006
PubMed
Summary

Maspin, a mammary serine protease inhibitor, is aberrantly expressed in endometrial cancer, particularly with squamous differentiation. DNA demethylation at the maspin promoter induces its expression, potentially influencing tumor cell differentiation.